Adverse Events of Axitinib plus Pembrolizumab Versus Lenvatinib plus Pembrolizumab: A Pharmacovigilance Study in Food and Drug Administration Adverse Event Reporting System
Adverse Events of Axitinib plus Pembrolizumab Versus Lenvatinib plus Pembrolizumab: A Pharmacovigilance Study in Food and Drug Administration Adverse Event Reporting System
复制标题
阿西替尼加派姆单抗与乐伐替尼加派姆单抗的不良事件：食品和药物管理局不良事件报告系统中的药物警戒研究
DOI：
10.1016/j.euf.2022.07.003
复制
发表时间：
2023
影响因子：
5.4
通讯作者：
Zamami Yoshito
中科院分区：
文献类型：
--
作者：
Matsumoto Jun;Iwata Naohiro;Watari Shogo;Ushio Soichiro;Shiromizu Shoya;Takeda Tatsuaki;Hamano Hirofumi;Kajizono Makoto;Araki Motoo;Nasu Yasutomo;Ariyoshi Noritaka;Zamami Yoshito
